D. Spriggs

527 total citations
22 papers, 436 citations indexed

About

D. Spriggs is a scholar working on Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Spriggs has authored 22 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Spriggs's work include Ovarian cancer diagnosis and treatment (6 papers), Blood properties and coagulation (4 papers) and Vibrio bacteria research studies (3 papers). D. Spriggs is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Blood properties and coagulation (4 papers) and Vibrio bacteria research studies (3 papers). D. Spriggs collaborates with scholars based in United States and Belgium. D. Spriggs's co-authors include Emil Frei, Fernando Cotait Maluf, D. Fennelly, Yutaka Hashimoto, Carol Aghajanian, F.L. Shapiro, R. Bradley Sack, Nadeem R. Abu‐Rustum, Janet Shimko and R.R. Barakat and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Infectious Diseases.

In The Last Decade

D. Spriggs

22 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Spriggs United States 13 135 96 82 69 67 22 436
Iwona Kątnik‐Prastowska Poland 15 30 0.2× 73 0.8× 247 3.0× 73 1.1× 41 0.6× 51 562
Per Ibsen Denmark 12 95 0.7× 130 1.4× 79 1.0× 153 2.2× 39 0.6× 17 766
Viveka Björklund Netherlands 8 119 0.9× 22 0.2× 229 2.8× 78 1.1× 32 0.5× 12 513
Susan P. Hubbard United States 9 155 1.1× 258 2.7× 106 1.3× 124 1.8× 17 0.3× 9 572
Yeh Chen Lee Australia 13 318 2.4× 227 2.4× 253 3.1× 91 1.3× 138 2.1× 51 791
Joseph Shuster Canada 15 105 0.8× 11 0.1× 155 1.9× 89 1.3× 28 0.4× 34 590
Smita Singh India 11 56 0.4× 23 0.2× 98 1.2× 39 0.6× 30 0.4× 44 355
P Piantino Italy 15 117 0.9× 14 0.1× 70 0.9× 144 2.1× 30 0.4× 43 1.0k
Emi Sato Japan 15 99 0.7× 79 0.8× 242 3.0× 42 0.6× 69 1.0× 59 679
Po-Hui Wang Taiwan 13 74 0.5× 61 0.6× 156 1.9× 41 0.6× 63 0.9× 30 386

Countries citing papers authored by D. Spriggs

Since Specialization
Citations

This map shows the geographic impact of D. Spriggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Spriggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Spriggs more than expected).

Fields of papers citing papers by D. Spriggs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Spriggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Spriggs. The network helps show where D. Spriggs may publish in the future.

Co-authorship network of co-authors of D. Spriggs

This figure shows the co-authorship network connecting the top 25 collaborators of D. Spriggs. A scholar is included among the top collaborators of D. Spriggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Spriggs. D. Spriggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tew, William P., Howard T. Thaler, Jason Konner, et al.. (2009). Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 27(15_suppl). 5541–5541. 2 indexed citations
3.
Leiser, Aliza, Fernando Cotait Maluf, D. S., et al.. (2007). A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. International Journal of Gynecological Cancer. 17(2). 379–386. 13 indexed citations
4.
Mooney, David, et al.. (2007). Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy. International Journal of Gynecological Cancer. 17(3). 589–594. 3 indexed citations
5.
Hensley, Martee L., James Larkin, Nicole Ishill, et al.. (2007). Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS). Journal of Clinical Oncology. 25(18_suppl). 5591–5591. 1 indexed citations
6.
Dupont, Jakob, Meghan Lovegren, Shaokun Chuai, et al.. (2006). Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?. International Journal of Gynecological Cancer. 16. 68–73. 3 indexed citations
7.
Dupont, Jakob, et al.. (2004). Phase I and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies. Journal of Clinical Oncology. 22(14_suppl). 3009–3009. 20 indexed citations
8.
McNamara, M., J. H. Doroshow, Jakob Dupont, et al.. (2004). Preliminary pharmacokinetics of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. Journal of Clinical Oncology. 22(14_suppl). 2073–2073. 3 indexed citations
9.
Maluf, Fernando Cotait & D. Spriggs. (2002). Anthracyclines in the Treatment of Gynecologic Malignancies. Gynecologic Oncology. 85(1). 18–31. 49 indexed citations
10.
Killeen, Kevin, D. Spriggs, & John J. Mekalanos. (1999). Bacterial Mucosal Vaccines: Vibrio cholerae as a Live Attenuated Vaccine/Vector Paradigm. Current topics in microbiology and immunology. 236. 237–254. 16 indexed citations
11.
Sack, David A., R. Bradley Sack, Janet Shimko, et al.. (1997). Evaluation of Peru‐15, a New Live Oral Vaccine for Cholera, in Volunteers. The Journal of Infectious Diseases. 176(1). 201–205. 34 indexed citations
12.
Abu‐Rustum, Nadeem R., Carol Aghajanian, R.R. Barakat, et al.. (1997). Salvage weekly paclitaxel in recurrent ovarian cancer.. PubMed. 24(5 Suppl 15). S15–62. 54 indexed citations
13.
Sack, David A., Janet Shimko, R. Bradley Sack, et al.. (1997). Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers. Infection and Immunity. 65(6). 2107–2111. 26 indexed citations
14.
15.
Takeyama, Hiroshi, Nobutaka Wakamiya, Carl O’Hara, et al.. (1991). Tumor necrosis factor expression by human ovarian carcinoma in vivo.. PubMed. 51(16). 4476–80. 48 indexed citations
16.
Frei, Emil & D. Spriggs. (1989). Tumor necrosis factor: still a promising agent.. Journal of Clinical Oncology. 7(3). 291–294. 52 indexed citations
17.
Spriggs, D., Herman K. Gold, Yutaka Hashimoto, et al.. (1989). Absence of Potentiation with Murine Antiplatelet GPIIb/IIIa Antibody of Thrombolysis with Recombinant Tissue-Type Plasminogen Activator (rt-PA) in a Canine Venous Thrombosis Model. Thrombosis and Haemostasis. 61(1). 93–96. 9 indexed citations
18.
19.
Holvoet, Paul, et al.. (1989). Binding Properties of Monoclonal Antibodies against Human Fragment D-Dimer of Cross-Linked Fibrin to Human Plasma Clots in an In Vivo Model in Rabbits. Thrombosis and Haemostasis. 61(2). 307–313. 27 indexed citations
20.
Hashimoto, Yuuri, et al.. (1988). 213 Thrombus imaging with 123I-labeled Fab fragments of two fibrin fragment D-dimer specific antibodies in a rabbit model of venous thrombosis. Fibrinolysis and Proteolysis. 2. 90–90. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iwona Kątnik‐Prastowska Breakdown of academic impact, for papers by Per Ibsen Breakdown of academic impact, for papers by Viveka Björklund Breakdown of academic impact, for papers by Susan P. Hubbard Breakdown of academic impact, for papers by Yeh Chen Lee Breakdown of academic impact, for papers by Joseph Shuster Breakdown of academic impact, for papers by Smita Singh Breakdown of academic impact, for papers by P Piantino Breakdown of academic impact, for papers by Emi Sato Breakdown of academic impact, for papers by Po-Hui Wang
Rankless by CCL
2026